Opthea Limited OPT.AX Stock
Opthea Limited Price Chart
Opthea Limited OPT.AX Financial and Trading Overview
| Opthea Limited stock price | 0.69 AUD |
| Previous Close | 0.56 AUD |
| Open | 0.57 AUD |
| Bid | 0.56 AUD x 0 |
| Ask | 0.58 AUD x 0 |
| Day's Range | 0.56 - 0.58 AUD |
| 52 Week Range | 0.56 - 1.39 AUD |
| Volume | 317.86K AUD |
| Avg. Volume | 423.7K AUD |
| Market Cap | 261.47M AUD |
| Beta (5Y Monthly) | 0.314559 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.46 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | October 11, 2004 |
| 1y Target Est | 6.88 AUD |
OPT.AX Valuation Measures
| Enterprise Value | 207.89M AUD |
| Trailing P/E | N/A |
| Forward P/E | -2.074074 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1077.3418 |
| Price/Book (mrq) | 4.6280994 |
| Enterprise Value/Revenue | 856.575 |
| Enterprise Value/EBITDA | -1.529 |
Trading Information
Opthea Limited Stock Price History
| Beta (5Y Monthly) | 0.314559 |
| 52-Week Change | -46.15% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.39 AUD |
| 52 Week Low | 0.56 AUD |
| 50-Day Moving Average | 0.66 AUD |
| 200-Day Moving Average | 0.88 AUD |
OPT.AX Share Statistics
| Avg. Volume (3 month) | 423.7K AUD |
| Avg. Daily Volume (10-Days) | 591.46K AUD |
| Shares Outstanding | 466.92M |
| Float | 306.83M |
| Short Ratio | N/A |
| % Held by Insiders | 8.98% |
| % Held by Institutions | 30.82% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -56036.65% |
| Gross Margin | 15.42% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -64.58% |
| Return on Equity (ttm) | -168.68% |
Income Statement
| Revenue (ttm) | 242.7K AUD |
| Revenue Per Share (ttm) | 0.001 AUD |
| Quarterly Revenue Growth (yoy) | 28.49% |
| Gross Profit (ttm) | 38.5K AUD |
| EBITDA | -135992272 AUD |
| Net Income Avi to Common (ttm) | -132203624 AUD |
| Diluted EPS (ttm) | -0.48 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 141.77M AUD |
| Total Cash Per Share (mrq) | 0.3 AUD |
| Total Debt (mrq) | 88.19M AUD |
| Total Debt/Equity (mrq) | 156.18 AUD |
| Current Ratio (mrq) | 16.322 |
| Book Value Per Share (mrq) | 0.121 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -111867136 AUD |
| Levered Free Cash Flow (ttm) | -72191792 AUD |
Profile of Opthea Limited
| Country | Australia |
| State | VIC |
| City | South Yarra |
| Address | 650 Chapel Street |
| ZIP | 3141 |
| Phone | 61 3 9826 0399 |
| Website | https://opthea.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema (DME), as well as a first in class VEGF-C/D inhibitors for treatment with VEGF-A inhibitors to treat wet neovascular AMD and other retinal diseases. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.
Q&A For Opthea Limited Stock
What is a current OPT.AX stock price?
Opthea Limited OPT.AX stock price today per share is 0.69 AUD.
How to purchase Opthea Limited stock?
You can buy OPT.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Opthea Limited?
The stock symbol or ticker of Opthea Limited is OPT.AX.
Which industry does the Opthea Limited company belong to?
The Opthea Limited industry is Biotechnology.
How many shares does Opthea Limited have in circulation?
The max supply of Opthea Limited shares is 662.81M.
What is Opthea Limited Price to Earnings Ratio (PE Ratio)?
Opthea Limited PE Ratio is now.
What was Opthea Limited earnings per share over the trailing 12 months (TTM)?
Opthea Limited EPS is -0.46 AUD over the trailing 12 months.
Which sector does the Opthea Limited company belong to?
The Opthea Limited sector is Healthcare.
Opthea Limited OPT.AX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
| ALL ORDINARIES AORD | 8014.4 AUD 5304.39 USD |
-0.44
|
— — | 7991.2 AUD 5289.03 USD | 8050.6 AUD 5328.35 USD | — - | — — |
- {{ link.label }} {{link}}